XML 72 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Information for Subsidiary Guarantors and Non-guarantor Subsidiaries (Tables)
9 Months Ended
Mar. 31, 2013
Financial Information for Subsidiary Guarantors and Non Guarantor Subsidiaries [Abstract]  
Condensed Consolidating Balance Sheets

Condensed Consolidating Balance Sheets
June 30, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$

 
$
305.8

 
$
149.7

 
$

 
$
455.5

Restricted cash

 

 

 
0.8

 
1.6

 

 
2.4

Accounts receivable, net

 

 

 
570.8

 
131.3

 

 
702.1

Inventories

 

 

 
93.2

 
3.8

 

 
97.0

Prepaid expenses and other current assets
0.1

 

 

 
281.8

 
44.1

 

 
326.0

Total current assets
0.1

 

 

 
1,252.4

 
330.5

 

 
1,583.0

Property, plant and equipment, net

 

 

 
1,802.6

 
307.5

 

 
2,110.1

Goodwill

 

 

 
680.9

 
87.5

 

 
768.4

Intangible assets, net

 
49.0

 
0.3

 
27.0

 
12.7

 

 
89.0

Investments in consolidated subsidiaries
608.8

 

 

 

 

 
(608.8
)
 

Investments in securities

 

 

 

 
51.8

 

 
51.8

Intercompany receivable

 
1,674.2

 

 

 

 
(1,674.2
)
 

Other assets

 

 

 
65.3

 
120.5

 

 
185.8

Total assets
$
608.9

 
$
1,723.2

 
$
0.3

 
$
3,828.2

 
$
910.5

 
$
(2,283.0
)
 
$
4,788.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
 

Accounts payable
$

 
$

 
$

 
$
316.8

 
$
73.8

 
$

 
$
390.6

Accrued expenses and other current liabilities
0.1

 
73.2

 

 
392.7

 
120.9

 

 
586.9

Current maturities of long-term debt

 
8.2

 

 
2.1

 
0.9

 

 
11.2

Total current liabilities
0.1

 
81.4

 

 
711.6

 
195.6

 

 
988.7

Other liabilities

 

 

 
547.6

 
201.8

 

 
749.4

Long-term debt, less current maturities

 
2,672.0

 
9.9

 
4.2

 
9.3

 

 
2,695.4

Intercompany payable
307.3

 

 
66.7

 
1,483.6

 
193.5

 
(2,051.1
)
 

Redeemable non-controlling interests

 

 

 

 
53.1

 

 
53.1

Total equity (deficit)
301.5

 
(1,030.2
)
 
(76.3
)
 
1,081.2

 
257.2

 
(231.9
)
 
301.5

Total liabilities and equity
$
608.9

 
$
1,723.2

 
$
0.3

 
$
3,828.2

 
$
910.5

 
$
(2,283.0
)
 
$
4,788.1



Condensed Consolidating Balance Sheets
March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$

 
$
425.6

 
$
97.2

 
$

 
$
522.8

Restricted cash

 

 

 
4.4

 
1.6

 

 
6.0

Accounts receivable, net

 

 

 
547.3

 
105.8

 

 
653.1

Inventories

 

 

 
88.1

 
11.1

 

 
99.2

Prepaid expenses and other current assets

 

 

 
227.2

 
61.1

 

 
288.3

Total current assets

 

 

 
1,292.6

 
276.8

 

 
1,569.4

Property, plant and equipment, net

 

 

 
1,903.1

 
299.5

 

 
2,202.6

Goodwill

 

 

 
672.2

 
100.3

 

 
772.5

Intangible assets, net

 
45.3

 

 
30.3

 
10.1

 

 
85.7

Investments in consolidated subsidiaries
608.8

 

 

 

 

 
(608.8
)
 

Investments in securities

 

 

 

 
59.3

 

 
59.3

Intercompany receivable

 
1,774.7

 

 

 

 
(1,774.7
)
 

Other assets

 

 

 
91.7

 
109.7

 

 
201.4

Total assets
$
608.8

 
$
1,820.0

 
$

 
$
3,989.9

 
$
855.7

 
$
(2,383.5
)
 
$
4,890.9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
 

Accounts payable
$

 
$

 
$

 
$
305.0

 
$
63.9

 
$

 
$
368.9

Accrued expenses and other current liabilities
0.1

 
27.8

 

 
346.2

 
98.7

 

 
472.8

Current maturities of long-term debt

 
10.9

 

 
2.7

 
0.9

 

 
14.5

Total current liabilities
0.1

 
38.7

 

 
653.9

 
163.5

 

 
856.2

Other liabilities

 

 

 
487.7

 
152.3

 

 
640.0

Long-term debt, less current maturities

 
2,965.8

 

 
8.1

 
6.9

 

 
2,980.8

Intercompany payable
251.2

 

 
78.4

 
1,644.7

 
177.3

 
(2,151.6
)
 

Redeemable non-controlling interests

 

 

 

 
56.4

 

 
56.4

Total equity (deficit)
357.5

 
(1,184.5
)
 
(78.4
)
 
1,195.5

 
299.3

 
(231.9
)
 
357.5

Total liabilities and equity
$
608.8

 
$
1,820.0

 
$

 
$
3,989.9

 
$
855.7

 
$
(2,383.5
)
 
$
4,890.9

Condensed Consolidating Statements of Operations

Condensed Consolidating Statements of Operations
For the three months ended March 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
1,245.5

 
$
155.5

 
$
(9.3
)
 
$
1,391.7

Premium revenues

 

 

 
23.5

 
171.0

 
(3.7
)
 
190.8

Total revenues

 

 

 
1,269.0

 
326.5

 
(13.0
)
 
1,582.5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
1.9

 

 

 
649.4

 
70.5

 

 
721.8

Health plan claims expense

 

 

 
7.6

 
148.3

 
(9.3
)
 
146.6

Supplies

 

 

 
209.7

 
25.8

 

 
235.5

Purchased services

 

 

 
122.9

 
21.7

 

 
144.6

Rents and leases

 

 

 
15.6

 
3.4

 

 
19.0

Other operating expenses
0.2

 

 

 
122.4

 
23.8

 
(3.7
)
 
142.7

Medicare and Medicaid EHR incentives

 

 

 
(2.4
)
 

 

 
(2.4
)
Depreciation and amortization

 

 

 
53.5

 
9.4

 

 
62.9

Interest, net

 
43.5

 
0.4

 
(4.7
)
 
4.2

 

 
43.4

Acquisition related expenses

 

 

 

 
1.2

 

 
1.2

Management fees

 

 

 
(7.6
)
 
7.6

 

 

Other

 

 

 
(2.2
)
 

 

 
(2.2
)
Income (loss) from continuing operations before income taxes
(2.1
)
 
(43.5
)
 
(0.4
)
 
104.8

 
10.6

 

 
69.4

Income tax benefit (expense)
(24.3
)
 

 

 

 
(4.5
)
 
4.5

 
(24.3
)
Equity in earnings of subsidiaries
70.4

 

 

 

 

 
(70.4
)
 

Income (loss) from continuing operations
44.0

 
(43.5
)
 
(0.4
)
 
104.8

 
6.1

 
(65.9
)
 
45.1

Loss from discontinued operations, net of taxes

 

 

 
(0.1
)
 

 

 
(0.1
)
Net income (loss)
44.0

 
(43.5
)
 
(0.4
)
 
104.7

 
6.1

 
(65.9
)
 
45.0

Net income attributable to non-controlling interests

 

 

 

 
(1.0
)
 

 
(1.0
)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
44.0

 
$
(43.5
)
 
$
(0.4
)
 
$
104.7

 
$
5.1

 
$
(65.9
)
 
$
44.0


Condensed Consolidating Statements of Operations
For the three months ended March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
1,058.4

 
$
264.0

 
$
(6.4
)
 
$
1,316.0

Premium revenues

 

 

 
52.6

 
129.5

 

 
182.1

Total revenues

 

 

 
1,111.0

 
393.5

 
(6.4
)
 
1,498.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
0.6

 

 

 
549.2

 
145.5

 

 
695.3

Health plan claims expense

 

 

 
9.2

 
134.5

 
(6.4
)
 
137.3

Supplies

 

 

 
201.1

 
28.0

 

 
229.1

Purchased services

 

 

 
122.1

 
33.5

 

 
155.6

Rents and leases

 

 

 
14.4

 
5.0

 

 
19.4

Other operating expenses
0.1

 

 

 
97.5

 
26.8

 

 
124.4

Medicare and Medicaid EHR incentives

 

 

 
(5.3
)
 
(0.1
)
 

 
(5.4
)
Depreciation and amortization

 

 

 
49.9

 
10.8

 

 
60.7

Interest, net

 
51.5

 
0.2

 
(10.0
)
 
7.1

 

 
48.8

Acquisition related expenses

 

 

 
0.1

 

 

 
0.1

Debt extinguishment costs

 
0.5

 
0.8

 

 

 

 
1.3

Management fees

 

 

 
(3.4
)
 
3.4

 

 

Other

 

 

 
(4.9
)
 

 

 
(4.9
)
Income (loss) from continuing operations before income taxes
(0.7
)
 
(52.0
)
 
(1.0
)
 
91.1

 
(1.0
)
 

 
36.4

Income tax benefit (expense)
(12.4
)
 

 

 

 
6.6

 
(6.6
)
 
(12.4
)
Equity in earnings of subsidiaries
34.4

 

 

 

 

 
(34.4
)
 

Net income (loss)
21.3

 
(52.0
)
 
(1.0
)
 
91.1

 
5.6

 
(41.0
)
 
24.0

Net loss attributable to non-controlling interests

 

 

 

 
(2.7
)
 

 
(2.7
)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
21.3

 
$
(52.0
)
 
$
(1.0
)
 
$
91.1

 
$
2.9

 
$
(41.0
)
 
$
21.3



Condensed Consolidating Statements of Operations
For the nine months ended March 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
3,541.6

 
$
384.4

 
$
(22.4
)
 
$
3,903.6

Premium revenues

 

 

 
63.4

 
538.5

 
(11.3
)
 
590.6

Total revenues

 

 

 
3,605.0

 
922.9

 
(33.7
)
 
4,494.2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
6.5

 

 

 
1,902.5

 
180.2

 

 
2,089.2

Health plan claims expense

 

 

 
23.9

 
457.1

 
(22.4
)
 
458.6

Supplies

 

 

 
613.4

 
63.6

 

 
677.0

Purchased services

 

 

 
349.4

 
55.6

 

 
405.0

Rents and leases

 

 

 
46.8

 
8.9

 

 
55.7

Other operating expenses
0.3

 

 

 
354.9

 
63.2

 
(11.3
)
 
407.1

Medicare and Medicaid EHR incentives

 

 

 
(26.8
)
 

 

 
(26.8
)
Depreciation and amortization

 

 

 
166.8

 
24.5

 

 
191.3

Interest, net

 
129.8

 
4.2

 
(12.3
)
 
10.7

 

 
132.4

Acquisition related expenses

 

 

 
8.0

 
5.8

 

 
13.8

Debt extinguishment costs

 

 
38.9

 

 

 

 
38.9

Management fees

 

 

 
(21.0
)
 
21.0

 

 

Other

 

 

 
(6.1
)
 
(0.3
)
 

 
(6.4
)
Income (loss) from continuing operations before income taxes
(6.8
)
 
(129.8
)
 
(43.1
)
 
205.5

 
32.6

 

 
58.4

Income tax benefit (expense)
(20.4
)
 

 

 

 
(14.2
)
 
14.2

 
(20.4
)
Equity in earnings of subsidiaries
65.2

 

 

 

 

 
(65.2
)
 

Income (loss) from continuing operations
38.0

 
(129.8
)
 
(43.1
)
 
205.5

 
18.4

 
(51.0
)
 
38.0

Loss from discontinued operations, net of taxes

 

 

 
(0.5
)
 

 

 
(0.5
)
Net income (loss)
38.0

 
(129.8
)
 
(43.1
)
 
205.0

 
18.4

 
(51.0
)
 
37.5

Net loss attributable to non-controlling interests

 

 

 

 
0.5

 

 
0.5

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
38.0

 
$
(129.8
)
 
$
(43.1
)
 
$
205.0

 
$
18.9

 
$
(51.0
)
 
$
38.0







Condensed Consolidating Statements of Operations
For the nine months ended March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
3,259.7

 
$
690.2

 
$
(19.8
)
 
$
3,930.1

Premium revenues

 

 

 
82.6

 
469.2

 

 
551.8

Total revenues

 

 

 
3,342.3

 
1,159.4

 
(19.8
)
 
4,481.9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
5.5

 

 

 
1,638.8

 
429.3

 

 
2,073.6

Health plan claims expense

 

 

 
26.2

 
415.0

 
(19.8
)
 
421.4

Supplies

 

 

 
608.8

 
78.9

 

 
687.7

Purchased services

 

 

 
354.5

 
96.5

 

 
451.0

Rents and leases

 

 

 
42.4

 
14.8

 

 
57.2

Other operating expenses
0.3

 

 

 
334.6

 
78.8

 

 
413.7

Medicare and Medicaid EHR incentives

 

 

 
(25.7
)
 
(5.5
)
 

 
(31.2
)
Depreciation and amortization

 

 

 
162.3

 
31.8

 

 
194.1

Interest, net

 
154.3

 
0.8

 
(27.8
)
 
22.0

 

 
149.3

Acquisition related expenses

 

 

 
0.2

 

 

 
0.2

Debt extinguishment costs

 
0.5

 
0.8

 

 

 

 
1.3

Management fees

 

 

 
(10.0
)
 
10.0

 

 

Other

 

 

 
(11.6
)
 
(0.2
)
 

 
(11.8
)
Income (loss) from continuing operations before income taxes
(5.8
)
 
(154.8
)
 
(1.6
)
 
249.6

 
(12.0
)
 

 
75.4

Income tax benefit (expense)
(24.5
)
 

 

 

 
(11.6
)
 
11.6

 
(24.5
)
Equity in earnings of subsidiaries
77.7

 

 

 

 

 
(77.7
)
 

Income (loss) from continuing operations
47.4

 
(154.8
)
 
(1.6
)
 
249.6

 
(23.6
)
 
(66.1
)
 
50.9

Income from discontinued operations, net of taxes

 

 

 
0.1

 

 

 
0.1

Net income (loss)
47.4

 
(154.8
)
 
(1.6
)
 
249.7

 
(23.6
)
 
(66.1
)
 
51.0

Net income attributable to non-controlling interests

 

 

 

 
(3.6
)
 

 
(3.6
)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
47.4

 
$
(154.8
)
 
$
(1.6
)
 
$
249.7

 
$
(27.2
)
 
$
(66.1
)
 
$
47.4

Condensed Statements of Comprehensive Income (Loss)

Condensed Consolidating Statements of Comprehensive Income (Loss)
For the three months ended March 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
44.0

 
$
(43.5
)
 
$
(0.4
)
 
$
104.7

 
$
6.1

 
$
(65.9
)
 
$
45.0

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
3.0

 

 
3.0

Other comprehensive income before taxes

 

 

 

 
3.0

 

 
3.0

Change in income tax expense

 

 

 

 
(1.0
)
 

 
(1.0
)
Other comprehensive income, net of taxes

 

 

 

 
2.0

 

 
2.0

Comprehensive income (loss)
44.0

 
(43.5
)
 
(0.4
)
 
104.7

 
8.1

 
(65.9
)
 
47.0

Net income attributable to non-controlling interests

 

 

 

 
(1.0
)
 

 
(1.0
)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
44.0

 
$
(43.5
)
 
$
(0.4
)
 
$
104.7

 
$
7.1

 
$
(65.9
)
 
$
46.0



Condensed Consolidating Statements of Comprehensive Income (Loss)
For the three months ended March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
21.3

 
$
(52.0
)
 
$
(1.0
)
 
$
91.1

 
$
5.6

 
$
(41.0
)
 
$
24.0

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
1.6

 

 
1.6

Other comprehensive income before taxes

 

 

 

 
1.6

 

 
1.6

Change in income tax expense

 

 

 

 
(0.7
)
 

 
(0.7
)
Other comprehensive income, net of taxes

 

 

 

 
0.9

 

 
0.9

Comprehensive income (loss)
21.3

 
(52.0
)
 
(1.0
)
 
91.1

 
6.5

 
(41.0
)
 
24.9

Net loss attributable to non-controlling interests

 

 

 

 
(2.7
)
 

 
(2.7
)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
21.3

 
$
(52.0
)
 
$
(1.0
)
 
$
91.1

 
$
3.8

 
$
(41.0
)
 
$
22.2



Condensed Consolidating Statements of Comprehensive Income (Loss)
For the nine months ended March 31, 2012

 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
38.0

 
$
(129.8
)
 
$
(43.1
)
 
$
205.0

 
$
18.4

 
$
(51.0
)
 
$
37.5

Other comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding losses on investments in securities, net

 

 

 

 
1.2

 

 
1.2

Other comprehensive loss before taxes

 

 

 

 
1.2

 

 
1.2

Change in income tax benefit

 

 

 

 
(0.2
)
 

 
(0.2
)
Other comprehensive loss, net of taxes

 

 

 

 
1.0

 

 
1.0

Comprehensive income (loss)
38.0

 
(129.8
)
 
(43.1
)
 
205.0

 
19.4

 
(51.0
)
 
38.5

Net loss attributable to non-controlling interests

 

 

 

 
0.5

 

 
0.5

Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
38.0

 
$
(129.8
)
 
$
(43.1
)
 
$
205.0

 
$
19.9

 
$
(51.0
)
 
$
39.0



Condensed Consolidating Statements of Comprehensive Income (Loss)
For the nine months ended March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
47.4

 
$
(154.8
)
 
$
(1.6
)
 
$
249.7

 
$
(23.6
)
 
$
(66.1
)
 
$
51.0

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
4.9

 

 
4.9

Other comprehensive income before taxes

 

 

 

 
4.9

 

 
4.9

Change in income tax expense

 

 

 

 
(2.1
)
 

 
(2.1
)
Other comprehensive income, net of taxes

 

 

 

 
2.8

 

 
2.8

Comprehensive income (loss)
47.4

 
(154.8
)
 
(1.6
)
 
249.7

 
(20.8
)
 
(66.1
)
 
53.8

Net income attributable to non-controlling interests

 

 

 

 
(3.6
)
 

 
(3.6
)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
47.4

 
$
(154.8
)
 
$
(1.6
)
 
$
249.7

 
$
(24.4
)
 
$
(66.1
)
 
$
50.2

Condensed Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows
For the nine months ended March 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
38.0

 
$
(129.8
)
 
$
(43.1
)
 
$
205.0

 
$
18.4

 
$
(51.0
)
 
$
37.5

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization

 

 

 
166.8

 
24.5

 

 
191.3

Amortization of loan costs

 
4.8

 

 

 

 

 
4.8

Accretion of principal on notes

 
2.0

 
4.2

 

 

 

 
6.2

Acquisition related expenses

 

 

 
8.0

 
5.8

 

 
13.8

Stock compensation
6.5

 

 

 

 

 

 
6.5

Deferred income taxes
15.4

 

 

 

 

 

 
15.4

Debt extinguishment costs

 

 
38.9

 

 

 

 
38.9

Other

 

 

 
(0.9
)
 

 

 
(0.9
)
Changes in operating assets and liabilities net of the impact of acquisitions
(59.9
)
 
(14.8
)
 

 
(248.7
)
 
(44.9
)
 
65.2

 
(303.1
)
Net cash provided by (used in) operating activities
$

 
$
(137.8
)
 
$

 
$
130.2

 
$
3.8

 
$
14.2

 
$
10.4



Condensed Consolidating Statements of Cash Flows
For the nine months ended March 31, 2012
(Continued)
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisitions and related expenses, net of cash acquired
$

 
$

 
$

 
$
(216.0
)
 
$
2.3

 
$

 
$
(213.7
)
Capital expenditures

 

 

 
(188.6
)
 
(7.5
)
 

 
(196.1
)
Net proceeds from sales of investments in securities

 

 

 
1.8

 
10.0

 

 
11.8

Net deposits to restricted cash and escrow fund

 

 

 
(40.6
)
 

 

 
(40.6
)
Other investing activities

 

 

 
2.4

 

 

 
2.4

Net cash provided by (used in) investing activities

 

 

 
(441.0
)
 
4.8

 

 
(436.2
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
 
 
 
 
 

Payments of long-term debt and capital lease obligations

 
(86.1
)
 
(457.4
)
 
(2.7
)
 
(1.5
)
 

 
(547.7
)
Proceeds from debt borrowings

 
452.2

 

 

 

 

 
452.2

Payments of debt issuance costs

 
(7.5
)
 

 

 

 

 
(7.5
)
Proceeds from issuance of common stock
67.5

 

 

 

 

 

 
67.5

Payments of IPO related costs
(6.9
)
 

 

 

 

 

 
(6.9
)
Payment of tender premiums on note redemption

 

 
(27.6
)
 

 

 

 
(27.6
)
Cash provided by (used in) intercompany activity
(59.6
)
 
(220.8
)
 
485.0

 
(23.9
)
 
(163.2
)
 
(17.5
)
 

Other financing activities
(1.0
)
 

 

 

 
(5.5
)
 
3.3

 
(3.2
)
Net cash provided by (used in) financing activities

 
137.8

 

 
(26.6
)
 
(170.2
)
 
(14.2
)
 
(73.2
)
Net decrease in cash and cash equivalents

 

 

 
(337.4
)
 
(161.6
)
 

 
(499.0
)
Cash and cash equivalents, beginning of period

 

 

 
644.1

 
292.5

 

 
936.6

Cash and cash equivalents, end of period
$

 
$

 
$

 
$
306.7

 
$
130.9

 
$

 
$
437.6



Condensed Consolidating Statements of Cash Flows
For the nine months ended March 31, 2013
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
47.4

 
$
(154.8
)
 
$
(1.6
)
 
$
249.7

 
$
(23.6
)
 
$
(66.1
)
 
$
51.0

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization

 

 

 
162.3

 
31.8

 

 
194.1

Amortization of loan costs

 
6.7

 

 

 

 

 
6.7

Accretion of principal on senior discount notes

 
2.5

 
0.7

 

 

 

 
3.2

Acquisition related expenses

 

 

 
0.2

 

 

 
0.2

Stock compensation
5.5

 

 

 

 

 

 
5.5

Deferred income taxes
12.8

 

 

 

 

 

 
12.8

Debt extinguishment costs

 
0.5

 
0.8

 

 

 

 
1.3

Other

 

 

 
1.2

 
0.4

 

 
1.6

Changes in operating assets and liabilities, net of impact of acquisitions
(65.7
)
 
(45.4
)
 

 
(25.6
)
 
(127.4
)
 
77.7

 
(186.4
)
Net cash provided by (used in) operating activities
$

 
$
(190.5
)
 
$
(0.1
)
 
$
387.8

 
$
(118.8
)
 
$
11.6

 
$
90.0



Condensed Consolidating Statements of Cash Flows
For the nine months ended March 31, 2013
(Continued)
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisitions and related expenses, net of cash acquired
$

 
$

 
$

 
$
(6.9
)
 
$
(0.3
)
 
$

 
$
(7.2
)
Capital expenditures

 

 

 
(270.9
)
 
(18.5
)
 

 
(289.4
)
Net purchases of investments in securities

 

 

 

 
(2.9
)
 

 
(2.9
)
Net reimbursements from restricted cash and escrow fund

 

 

 
0.3

 

 

 
0.3

Other investing activities

 

 

 
(0.4
)
 

 

 
(0.4
)
Net cash used in investing activities

 

 

 
(277.9
)
 
(21.7
)
 

 
(299.6
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
 
 
 
 
 

Payments of long-term debt and capital lease obligations

 
(6.0
)
 
(10.6
)
 
(0.4
)
 
(2.1
)
 

 
(19.1
)
Proceeds from debt borrowings

 
300.0

 

 

 

 

 
300.0

Payments of debt issuance costs

 
(2.6
)
 

 

 

 

 
(2.6
)
Payments of tender premiums on note redemption

 

 
(0.5
)
 

 

 

 
(0.5
)
Other financing activities
(0.4
)
 

 

 

 
(0.5
)
 

 
(0.9
)
Cash provided by (used in) intercompany activity
0.4

 
(100.9
)
 
11.2

 
10.3

 
90.6

 
(11.6
)
 

Net cash provided by (used in) financing activities

 
190.5

 
0.1

 
9.9

 
88.0

 
(11.6
)
 
276.9

Net decrease in cash and cash equivalents

 

 

 
119.8

 
(52.5
)
 

 
67.3

Cash and cash equivalents, beginning of period

 

 

 
305.8

 
149.7

 

 
455.5

Cash and cash equivalents, end of period
$

 
$

 
$

 
$
425.6

 
$
97.2

 
$

 
$
522.8